161 related articles for article (PubMed ID: 30597115)
1. No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat.
Stamp LK; Topless R; Miner JN; Dalbeth N; Merriman T
Rheumatology (Oxford); 2019 Mar; 58(3):547-548. PubMed ID: 30597115
[No Abstract] [Full Text] [Related]
2. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
3. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
4. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.
Roberts RL; Wallace MC; Phipps-Green AJ; Topless R; Drake JM; Tan P; Dalbeth N; Merriman TR; Stamp LK
Pharmacogenomics J; 2017 Mar; 17(2):201-203. PubMed ID: 26810134
[TBL] [Abstract][Full Text] [Related]
5. ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population.
Zhang K; Li C
Hereditas; 2019; 156():26. PubMed ID: 31367212
[TBL] [Abstract][Full Text] [Related]
6. Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.
Wallace MC; Roberts RL; Nanavati P; Miner JN; Dalbeth N; Topless R; Merriman TR; Stamp LK
Rheumatology (Oxford); 2018 Apr; 57(4):656-660. PubMed ID: 29342288
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort.
Roman Y; Tiirikainen M; Prom-Wormley E
Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664
[TBL] [Abstract][Full Text] [Related]
9. Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study.
Zhang L; Spencer KL; Voruganti VS; Jorgensen NW; Fornage M; Best LG; Brown-Gentry KD; Cole SA; Crawford DC; Deelman E; Franceschini N; Gaffo AL; Glenn KR; Heiss G; Jenny NS; Kottgen A; Li Q; Liu K; Matise TC; North KE; Umans JG; Kao WH
Am J Epidemiol; 2013 May; 177(9):923-32. PubMed ID: 23552988
[TBL] [Abstract][Full Text] [Related]
10. Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration.
Stamp LK; Chapman PT; Barclay M; Horne A; Frampton C; Merriman TR; Wright DFB; Drake J; Dalbeth N
Clin Transl Sci; 2020 Jan; 13(1):110-115. PubMed ID: 31444839
[TBL] [Abstract][Full Text] [Related]
11. The association between the polymorphism rs2231142 in the ABCG2 gene and gout risk: a meta-analysis.
Lv X; Zhang Y; Zeng F; Yin A; Ye N; Ouyang H; Feng D; Li D; Ling W; Zhang X
Clin Rheumatol; 2014 Dec; 33(12):1801-5. PubMed ID: 24777469
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.
Yu KH; Lai JH; Hsu PN; Chen DY; Chen CJ; Lin HY
Scand J Rheumatol; 2016 Jul; 45(4):304-11. PubMed ID: 26771445
[TBL] [Abstract][Full Text] [Related]
13. Mediation analysis to understand genetic relationships between habitual coffee intake and gout.
Hutton J; Fatima T; Major TJ; Topless R; Stamp LK; Merriman TR; Dalbeth N
Arthritis Res Ther; 2018 Jul; 20(1):135. PubMed ID: 29976226
[TBL] [Abstract][Full Text] [Related]
14. Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus.
Zaidi F; Narang RK; Phipps-Green A; Gamble GG; Tausche AK; So A; Riches P; Andres M; Perez-Ruiz F; Doherty M; Janssen M; Joosten LAB; Jansen TL; Kurreeman F; Torres RJ; McCarthy GM; Miner JN; Stamp LK; Merriman TR; Dalbeth N
Rheumatology (Oxford); 2020 Sep; 59(9):2544-2549. PubMed ID: 31998961
[TBL] [Abstract][Full Text] [Related]
15. Functional non-synonymous variants of ABCG2 and gout risk.
Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
[TBL] [Abstract][Full Text] [Related]
16. The ABCG2 gene Q141K polymorphism contributes to an increased risk of gout: a meta-analysis of 2185 cases.
Qiu Y; Liu H; Qing Y; Yang M; Tan X; Zhao M; Lin M; Zhou J
Mod Rheumatol; 2014 Sep; 24(5):829-34. PubMed ID: 24499401
[TBL] [Abstract][Full Text] [Related]
17. Advances in Urate-Lowering Therapy: Time to Revisit High-Dose Febuxostat.
Abeles AM
Am J Ther; 2017 May; 24(3):e241-e242. PubMed ID: 28291044
[No Abstract] [Full Text] [Related]
18. [Meta-analysis on relationship between single nucleotide polymorphism of rs2231142 in ABCG2 gene and gout in East Asian population].
Wu L; He Y; Zhang D
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Nov; 36(11):1291-6. PubMed ID: 26850254
[TBL] [Abstract][Full Text] [Related]
19. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
20. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2.
Toyoda Y; Pavelcová K; Klein M; Suzuki H; Takada T; Stiburkova B
Arthritis Res Ther; 2019 Oct; 21(1):219. PubMed ID: 31661014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
